health & science•Sun, September 6, 2026•4 min read

The 50% Coin Flip: Why Your Norovirus Test Might Be Misleading You

Researchers at the University of Washington have discovered that a widely used diagnostic test for norovirus frequently misidentifies common gut bacteria as the virus. This flaw has led to a staggering 50% false-positive rate in some clinical settings.

A Diagnostic Mystery

If you have spent time dealing with a sudden bout of diarrhea or vomiting, you might have been told you have norovirus. But according to a new study from the University of Washington School of Medicine, there is a strong possibility that diagnosis was incorrect. Researchers found that a widely used laboratory diagnostic tool is frequently triggering false-positive results, effectively turning a medical diagnosis into a coin flip.

What Went Wrong with the Test

The study focuses on the BioFire FilmArray Gastrointestinal (GI) Panel, manufactured by bioMérieux. This diagnostic tool utilizes reverse transcription polymerase chain reaction (RT-PCR) to detect pathogen DNA in stool samples. While this technology is generally considered the gold standard for identifying gastrointestinal illnesses, investigators discovered a significant technical flaw.

The researchers found that the test's primers—the molecules used to target and replicate viral DNA—were inadvertently reacting to the genetic material of 78 different bacterial species. These bacteria are not harmful pathogens; they are common, healthy microbes naturally present in the human intestine.

The BioFire GI Panel misidentified common gut bacteria as norovirus.
The cross-reactivity involved 78 different species of bacteria.
False-positive rates at hospitals ranged from 31% to 74%.
On average, patients faced a 50% chance that a positive result was incorrect.

It was basically a coin flip whether your patient had norovirus or not.
— Dr. Alexander Greninger, senior author of the study and professor of laboratory medicine and pathology at the UW School of Medicine

Why It Matters

The implications of these findings are broad. Norovirus is highly contagious, and reports of outbreaks typically surge during the winter months. When labs reported high numbers of 'norovirus' cases during the summer, medical professionals were immediately suspicious. This diagnostic discrepancy is estimated to have caused more than 250,000 false-positive results since 2019.

Accurate testing is essential not just for individual patient care, but for public health tracking. Misidentifying the cause of gastrointestinal outbreaks can lead to unnecessary isolation protocols, skewed public health data, and ineffective treatment plans. As researchers continue to refine diagnostic tools, this study serves as a critical reminder of the importance of questioning laboratory results that seem inconsistent with the timing and nature of reported symptoms.

Key Takeaways

A UW study identified a flaw in the BioFire GI Panel that causes false-positive norovirus results.
The test's primers cross-react with 78 common, harmless gut bacteria species.
Data shows that over 250,000 false-positive results have occurred since 2019.
Hospital false-positive rates ranged significantly, averaging roughly 50%.
The findings highlight the risks of relying on diagnostic assays that may not be specific enough for certain pathogens.

FAQ

What test was found to be misdiagnosing norovirus?

The study identified the BioFire FilmArray Gastrointestinal (GI) Panel, manufactured by bioMérieux, as the test frequently producing false-positive results.

Why does the test give a false positive?

The test's primers mistakenly target and amplify the DNA of 78 different species of common gut bacteria instead of just the norovirus.

How high is the false-positive rate?

Researchers found that the false-positive rate varied between hospitals, ranging from 31% to 74%, with an average of about 50%.

Does this mean norovirus tests are useless?

No. While this specific panel has significant cross-reactivity issues, RT-qPCR assays remain the preferred and sensitive method for detecting norovirus when used correctly.